It might be one in a few hundred patients who experience a gallbladder condition due to GLP-1 drug use, says Dr
Ultimately, the best treatment choice depends on your individual health status, goals, and preferences
Compounded semaglutide is a GLP-1 receptor agonist prepared by U.S.-licensed compounding pharmacies in accordance with applicable federal and state regulations
FXR an emerging therapeutic target for the treatment of atherosclerosis
95% CI: 1.10, 1.35), while risks of mortality and overall major adverse cardiac events (acute myocardial infarction, cerebral infarction, and/or mortality) were reduced (respectively, HR 0.48 with 95% CI of 0.28, 0.80